Business Context and Reporting Period
The filing is PowerVerde, Inc.’s Form 10-K for the fiscal year ended December 31, 2017, filed April 17, 2018. The request identifies the company as 374Water Inc., but the supplied filing names PowerVerde, Inc.; this identity discrepancy should be verified.
PowerVerde is a development-stage clean-energy company pursuing waste-heat and pressure-driven electric power systems, including organic Rankine cycle technology. The company has not generated material revenue from its planned power-generation operations. Its historical revenue primarily came from an unrelated biotech intellectual-property licensing arrangement.
Financial Metrics
| Metric | 2017 | 2016 |
|---|---|---|
| Revenue | $852,443 | $587,613 |
| Research and development expense | $210,624 | $331,038 |
| General and administrative expense | $210,491 | $318,067 |
| Operating income (loss) | $431,328 | $(61,492) |
| Net income (loss) | $404,353 | $(123,762) |
| Net income (loss) per share | $0.01 | $(0.00) |
| Cash used in operating activities | $(271,550) | $(146,754) |
| Cash and cash equivalents at year-end | $1,336 | $4,786 |
| Working capital | $168,859 | $(272,120) |
| Related-party notes payable | $150,000 | $425,000 |
| Accumulated deficit | $(11,378,720) | $(11,783,073) |
Licensing revenue was $818,443 in 2017, representing approximately 96% of total revenue; the remaining $34,000 came from part-time skilled manufacturing services. The filing does not provide a meaningful operating margin for the planned clean-energy business because that business generated no revenue. Based on reported revenue and operating income, the consolidated 2017 operating margin was approximately 50.6%, versus approximately negative 10.5% in 2016, primarily because of licensing revenue rather than product commercialization.
Total assets were $508,763 at December 31, 2017, including $369,959 of accounts receivable. Total liabilities were $245,310, and stockholders’ equity was $263,453. The company paid $275,000 of related-party note principal during 2017; the remaining $150,000 was paid in January 2018.
Material Changes Versus the Prior Comparable Period
- Revenue increased 45.1% to $852,443, driven principally by higher biotech licensing fees.
- Research and development expense declined 36.4%, and general and administrative expense declined to $210,491 from $318,067; management attributed the expense reduction primarily to fewer stock-option issuances and cost controls.
- The company moved from a 2016 net loss of $123,762 to 2017 net income of $404,353, although operating cash flow remained negative.
- Working capital improved from a deficit of $272,120 to positive working capital of $168,859, principally because of increased licensing revenue.
- Cash remained minimal and declined to $1,336 despite the reported net income, reflecting negative operating cash flow and debt repayments.
- The accumulated deficit improved to $11.4 million but remains substantial.
Guidance, Outlook, Risks, Contingencies and Unusual Items
The biotech license agreement expired in March 2018 when the underlying patents expired. Management expected a final royalty payment of $159,094 in the second quarter of 2018 for royalties accrued through the first quarter. Thereafter, the company expected no material recurring revenue unless it commercialized its clean-energy systems or secured another funding or revenue source.
In late December 2017, Duke University selected PowerVerde exclusively under a competitive request-for-proposal process to develop an expander for a proposed supercritical water oxidation sanitation project, initially contemplated at approximately 100 systems. The project was at an early stage, and no assurance was provided regarding technical success, financing, commercialization, or profitability.
Management stated that it needed to promptly raise substantial additional debt or equity capital and might be forced to cease operations if financing could not be obtained on acceptable terms. The independent auditor identified substantial doubt about the company’s ability to continue as a going concern because of recurring losses, negative operating cash flow, dependence on the expired license, and limited alternative revenue sources.
The company continued to face unresolved technical issues, including the inability to demonstrate the continuous operating duration required for commercial-quality waste-heat systems. It had sold only one system, at a discount, and had generated no material product-sales revenue.
- In the third quarter of 2017, the company wrote off $38,750 paid to Helidyne after Helidyne failed to perform under its expander license arrangement.
- The company entered into a manufacturing assembly agreement with Liberty Plugins and reported approximately $34,807 of revenue from 34 electric-vehicle charging systems assembled and shipped in 2017.
- The Liberty receivable was converted into a 12% promissory note, with the balance increased to $34,000 and maturity extended to April 30, 2018.
- Accounts receivable and prepaid expenses reduced operating cash flow by $184,730 in 2017.
- The company had one full-time employee and used a part-time consulting arrangement for its chief design engineer.
- The common stock traded thinly on the OTCBB, paid no dividends, and was subject to penny-stock restrictions and significant dilution risk from outstanding warrants and options.
Important Facts for Investors to Verify
- Verify whether this filing belongs to 374Water Inc. or PowerVerde, Inc.; the supplied document identifies PowerVerde.
- Confirm the post-March 2018 loss of the biotech licensing revenue stream and whether the expected final royalty payment was received.
- Review subsequent financing, liquidity, and any disclosures addressing the auditor’s going-concern uncertainty.
- Assess whether the Duke sanitation project advanced beyond selection, obtained financing, and generated contracts or revenue.
- Confirm that the company has commercialized its clean-energy systems; the filing reports no material product-sales revenue.
- Review the status and potential dilution from 3,675,000 outstanding warrants and 5,750,000 outstanding options as of December 31, 2017.
- Evaluate collectibility of the Liberty promissory note and the company’s remaining accounts receivable.
- Consider the company’s minimal cash balance, negative operating cash flow, expired principal revenue source, and stated risk of ceasing operations without new capital.